Immunotherapy of radioresistant mammary tumors with early metastasis using molecular chaperone vaccines combined with ionizing radiation

Journal of Immunology

Volumn 191, Issue 2, 2013, Pages 755-763

  Weng, Desheng ^a,b   Song, Baizheng ^a   Koido, Shigeo ^c   Calderwood, Stuart K ^d   Gong, Jianlin ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; DENDRITIC CELL HEAT SHOCK PROTEIN 70 PEPTIDE COMPLEX VACCINE; DENDRITIC CELL VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER IMMUNIZATION; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER STEM CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG CYTOTOXICITY; DRUG TARGETING; EFFECTOR CELL; FEMALE; IMMUNOSTIMULATION; IONIZING RADIATION; LUNG METASTASIS; LYMPHOCYTE PROLIFERATION; METASTASIS INHIBITION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION; TREATMENT OUTCOME;

ANIMALS; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL FUSION; CELL PROLIFERATION; COMBINED MODALITY THERAPY; DENDRITIC CELLS; FEMALE; HSP70 HEAT-SHOCK PROTEINS; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNOTHERAPY; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR CHAPERONES; RADIATION TOLERANCE; RADIATION, IONIZING; RETROVIRIDAE INFECTIONS; TUMOR VIRUS INFECTIONS; VACCINES, SYNTHETIC;

EID: 84880111912     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203286     Document Type: Article

References (60)

1. Trott, K. R. 1994. Tumour stem cells: the biological concept and its application in cancer treatment. Radiother. Oncol. 30: 1-5. (Pubitemid 24056900)
2. Debeb, B. G., W. Xu, and W. A. Woodward. 2009. Radiation resistance of breast cancer stem cells: understanding the clinical framework. J. Mammary Gland Biol. Neoplasia 14: 11-17.
3. Al-Hajj, M., M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke. 2003. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100: 3983-3988. (Pubitemid 36418143)
4. Welm, B. E., S. B. Tepera, T. Venezia, T. A. Graubert, J. M. Rosen, and M. A. Goodell. 2002. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol. 245: 42-56. (Pubitemid 34461802)
5. Welm, B., F. Behbod, M. A. Goodell, and J. M. Rosen. 2003. Isolation and characterization of functional mammary gland stem cells. Cell Prolif. 36(Suppl. 1): 17-32. (Pubitemid 37521841)
6. Chen, M. S., W. A. Woodward, F. Behbod, S. Peddibhotla, M. P. Alfaro, T. A. Buchholz, and J. M. Rosen. 2007. Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J. Cell Sci. 120: 468-477. (Pubitemid 46332510)
7. Dontu, G., W. M. Abdallah, J. M. Foley, K. W. Jackson, M. F. Clarke, M. J. Kawamura, and M. S. Wicha. 2003. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17: 1253-1270. (Pubitemid 36583168)
8. Phillips, T. M., W. H. McBride, and F. Pajonk. 2006. The response of CD24 (-/low)/CD44+ breast cancer-initiating cells to radiation. J. Natl. Cancer Inst. 98: 1777-1785. (Pubitemid 46017929)
9. Pellegatta, S., P. L. Poliani, D. Corno, F. Menghi, F. Ghielmetti, B. Suarez-Merino, V. Caldera, S. Nava, M. Ravanini, F. Facchetti, et al. 2006. Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res. 66: 10247-10252. (Pubitemid 44799739)
10. Xu, Q., G. Liu, X. Yuan, M. Xu, H. Wang, J. Ji, B. Konda, K. L. Black, and J. S. Yu. 2009. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells 27: 1734-1740.
11. Mine, T., S. Matsueda, Y. Li, H. Tokumitsu, H. Gao, C. Danes, K. K. Wong, X. Wang, S. Ferrone, and C. G. Ioannides. 2009. Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells. Cancer Immunol. Immunother. 58: 1185-1194.
12. Pellegatta, S., and G. Finocchiaro. 2009. Dendritic cell vaccines for cancer stem cells. Methods Mol. Biol. 568: 233-247.
13. Engelhard, V. H., T. N. Bullock, T. A. Colella, S. L. Sheasley, and D. W. Mullins. 2002. Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy. Immunol. Rev. 188: 136-146. (Pubitemid 35398871)
14. Disis, M. L., and M. A. Cheever. 1996. Oncogenic proteins as tumor antigens. Curr. Opin. Immunol. 8: 637-642. (Pubitemid 26385391)
15. Srivastava, P. K. 2000. Heat shock protein-based novel immunotherapies. Drug News Perspect. 13: 517-522. (Pubitemid 32120907)
16. Srivastava, P. K., and R. J. Amato. 2001. Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents. Vaccine 19: 2590-2597. (Pubitemid 32234277)
17. Calderwood, S. K., J. Gong, J. R. Theriault, S. S. Mambula, and P. J. Gray, Jr. 2008. Cell stress proteins: novel immunotherapeutics. Novartis Found. Symp. 291: 115-131, discussion 131-140.
18. Lindquist, S., and E. A. Craig. 1988. The heat-shock proteins. Annu. Rev. Genet. 22: 631-677. (Pubitemid 19156675)
19. Wegele, H., L. Müller, and J. Buchner. 2004. Hsp70 and Hsp90 - a relay team for protein folding. Rev. Physiol. Biochem. Pharmacol. 151: 1-44.
20. Young, J. C., V. R. Agashe, K. Siegers, and F. U. Hartl. 2004. Pathways of chaperone-mediated protein folding in the cytosol. Nat. Rev. Mol. Cell Biol. 5: 781-791. (Pubitemid 39336272)
21. Qian, S. B., H. McDonough, F. Boellmann, D. M. Cyr, and C. Patterson. 2006. CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70. Nature 440: 551-555.
22. Mayer, M. P., and B. Bukau. 2005. Hsp70 chaperones: cellular functions and molecular mechanism. Cell. Mol. Life Sci. 62: 670-684.
23. Spiess, C., A. S. Meyer, S. Reissmann, and J. Frydman. 2004. Mechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets. Trends Cell Biol. 14: 598-604. (Pubitemid 39440608)
24. Calderwood, S. K., J. R. Theriault, and J. Gong. 2005. Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity. Eur. J. Immunol. 35: 2518-2527. (Pubitemid 41404034)
25. Arnold-Schild, D., D. Hanau, D. Spehner, C. Schmid, H. G. Rammensee, H. de la Salle, and H. Schild. 1999. Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J. Immunol. 162: 3757-3760. (Pubitemid 29314749)
26. Binder, R. J., D. K. Han, and P. K. Srivastava. 2000. CD91: a receptor for heat shock protein gp96. Nat. Immunol. 1: 151-155.
27. Binder, R. J., and P. K. Srivastava. 2005. Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells. Nat. Immunol. 6: 593-599. (Pubitemid 41710730)
28. Murshid, A., J. Gong, M. A. Stevenson, and S. K. Calderwood. 2011. Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come. Expert Rev. Vaccines 10: 1553-1568.
29. Murshid, A., J. Gong, and S. K. Calderwood. 2012. The role of heat shock proteins in antigen cross presentation. Front. Immunol. 3: 63.
30. Rowse, G. J., R. M. Tempero, M. L. VanLith, M. A. Hollingsworth, and S. J. Gendler. 1998. Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. Cancer Res. 58: 315-321. (Pubitemid 28047073)
31. Xia, J., Y. Tanaka, S. Koido, C. Liu, P. Mukherjee, S. J. Gendler, and J. Gong. 2003. Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells. J. Immunol. 170: 1980-1986. (Pubitemid 36197418)
32. Guy, C. T., R. D. Cardiff, and W. J. Muller. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12: 954-961.
33. Basu, D., T. T. Nguyen, K. T. Montone, G. Zhang, L. P. Wang, J. A. Diehl, A. K. Rustgi, J. T. Lee, G. S. Weinstein, and M. Herlyn. 2010. Evidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity. Oncogene 29: 4170-4182.
34. Swope, V. B., A. P. Supp, D. G. Greenhalgh, G. D. Warden, and S. T. Boyce. 2001. Expression of insulin-like growth factor I by cultured skin substitutes does not replace the physiologic requirement for insulin in vitro. J. Invest. Dermatol. 116: 650-657. (Pubitemid 32467641)
35. Franken, N. A., H. M. Rodermond, J. Stap, J. Haveman, and C. van Bree. 2006. Clonogenic assay of cells in vitro. Nat. Protoc. 1: 2315-2319.
36. Amorino, G. P., R. B. Mikkelsen, K. Valerie, and R. K. Schmidt-Ullrich. 2003. Dominant-negative cAMP-responsive element-binding protein inhibits proliferating cell nuclear antigen and DNA repair, leading to increased cellular radiosensitivity. J. Biol. Chem. 278: 29394-29399. (Pubitemid 36962318)
37. Hall, E. J., and A. J. Giaccia. 2006. Radiobiology for the Radiologist. Lippincott Wilkins & Williams, Philadelphia.
38. Pulaski, B. A., and S. Ostrand-Rosenberg. 1998. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res. 58: 1486-1493. (Pubitemid 28193612)
39. Jaskelioff, M., W. Song, J. Xia, C. Liu, J. Kramer, S. Koido, S. J. Gendler, S. K. Calderwood, and J. Gong. 2009. Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene. Oncogene 28: 4225-4236.
40. Weng, D., J. H. Penzner, B. Song, S. Koido, S. K. Calderwood, and J. Gong. 2012. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers. Breast Cancer Res. 14: R18.
41. Woodward, W. A., M. S. Chen, F. Behbod, M. P. Alfaro, T. A. Buchholz, and J. M. Rosen. 2007. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc. Natl. Acad. Sci. USA 104: 618-623. (Pubitemid 46123074)
42. Weng, D., B. Song, J. Durfee, V. Sugiyama, Z. Wu, S. Koido, S. K. Calderwood, and J. Gong. 2011. Induction of cytotoxic T lymphocytes against ovarian cancer-initiating cells. Int. J. Cancer 129: 1990-2001.
43. Enomoto, Y., A. Bharti, A. A. Khaleque, B. Song, C. Liu, V. Apostolopoulos, P. X. Xing, S. K. Calderwood, and J. Gong. 2006. Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells. J. Immunol. 177: 5946-5955. (Pubitemid 44628808)
44. Tanaka, Y., S. Koido, M. Ohana, C. Liu, and J. Gong. 2005. Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells. J. Immunol. 174: 1274-1280.
45. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
46. Gong, J., D. Chen, M. Kashiwaba, and D. Kufe. 1997. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat. Med. 3: 558-561. (Pubitemid 27198656)
47. Clarke, M., R. Collins, S. Darby, C. Davies, P. Elphinstone, E. Evans, J. Godwin, R. Gray, C. Hicks, S. James, et al Early Breast Cancer Trialists' Collaborative Group (EBCTCG). 2005. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087-2106. (Pubitemid 41797643)
48. Gebski, V., M. Lagleva, A. Keech, J. Simes, and A. O. Langlands. 2006. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective. J. Natl. Cancer Inst. 98: 26-38. (Pubitemid 43057090)
49. Riesterer, O., L. Milas, and K. K. Ang. 2007. Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy. J. Clin. Oncol. 25: 4075-4083. (Pubitemid 47495867)
50. Wright, E. A., and P. Howard-Flanders. 1957. The influence of oxygen on the radiosensitivity of mammalian tissues. Acta Radiol. 48: 26-32.
51. Baumann, M., W. Dubois, and H. D. Suit. 1990. Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units. Radiat. Res. 123: 325-330. (Pubitemid 20327905)
52. Hill, R. P., and L. Milas. 1989. The proportion of stem cells in murine tumors. Int. J. Radiat. Oncol. Biol. Phys. 16: 513-518. (Pubitemid 19077222)
53. Yaromina, A., M. Krause, H. Thames, A. Rosner, M. Krause, F. Hessel, R. Grenman, D. Zips, and M. Baumann. 2007. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiother. Oncol. 83: 304-310. (Pubitemid 46915546)
54. Lobo, N. A., Y. Shimono, D. Qian, and M. F. Clarke. 2007. The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 23: 675-699.
55. Finn, O. J. 2003. Cancer vaccines: between the idea and the reality. Nat. Rev. Immunol. 3: 630-641. (Pubitemid 37328666)
56. Gong, J. 2006. Immunotherapy of cancer based on DC-tumor fusion vaccine. Curr. Immunol. Rev. 2: 291-304.
57. Rosenberg, S. A., J. C. Yang, and N. P. Restifo. 2004. Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10: 909-915. (Pubitemid 39273730)
58. Gong, J., Y. Zhang, J. Durfee, D. Weng, C. Liu, S. Koido, B. Song, V. Apostolopoulos, and S. K. Calderwood. 2010. A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use. J. Immunol. 184: 488-496.
59. Galluzzi, L., M. C. Maiuri, I. Vitale, H. Zischka, M. Castedo, L. Zitvogel, and G. Kroemer. 2007. Cell death modalities: classification and pathophysiological implications. Cell Death Differ. 14: 1237-1243. (Pubitemid 46969863)
60. Formenti, S. C., and S. Demaria. 2009. Systemic effects of local radiotherapy. Lancet Oncol. 10: 718-726.